Phillip Scheinberg, MD, Reports on MDS From the Eleventh Annual SOHO Meeting

Dr. Scheinberg reports on what he finds interesting in myelodysplastic syndromes (MDS) from the Eleventh Annual Meeting of the Society of Hematologic Oncology.

“There’s been a lot of focus on classifications and mutations: they’re coming with a lot of force,” Dr. Scheinberg said. “More and more, we’re applying this technology to better risk stratify our patients, and we have seen examples—which was shown in the sessions—of patients who are upstaged based on their mutational profile.”